James C. Willey - Publications

TP53-mutated preneoplastic colonies, adaptive immune response, and risk for lung cancer and COPD.

Journal: Cancer prevention research (Philadelphia, Pa.)

Published: April 10, 2026

Leveraging Commercially Available Protein Assays as Biomarkers for Lung Cancer.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: December 16, 2025

Microcystin-LR aerosol exposure increases inflammatory drivers of asthma, Evidence of an NF-κB amplification mechanism.

Journal: bioRxiv : the preprint server for biology

Published: September 26, 2025

High-Penetrance Rare Variants Underlying Familial Lung Cancer Risk: Insights From Genetic Epidemiology of Lung Cancer Consortium.

Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer

Published: August 21, 2025

Augmenting precision medicine via targeted RNA-Seq detection of expressed mutations.

Journal: NPJ precision oncology

Published: November 08, 2024

Aerosolized Harmful Algal Bloom Toxin Microcystin-LR Induces Type 1/Type 17 Inflammation of Murine Airways.

Journal: Toxins

Published: September 24, 2024

Lung Cancer in Ever- and Never-Smokers: Findings from Multi-Population GWAS Studies.

Journal: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology

Published: May 26, 2023